Description
| Strength | 150 mcg |
| Brand Name | Anti D |
| Manufacturer | BSV |
| Packaging Type | Box |
| Usage/Application | To Prevent A Disease Called Rhesus Disease. |
| Shelf Life | 36 Months |
| Composition | Trinbelimab (Anti-D immunoglobulin) |
| Form | Injection |
Product’s Details:
- Anti D (Trinbelimab) is a highly purified, human anti-D immunoglobulin injection indicated for the prevention of Rh isoimmunization in Rh-negative individuals.
- Mechanism of Action: Anti-D immunoglobulin prevents the maternal immune system from recognizing and responding to Rh(D)-positive fetal red blood cells, thereby reducing the risk of hemolytic disease of the newborn in future pregnancies.
- Indications:
- Routine antenatal prophylaxis at 28 weeks gestation in Rh-negative women
- Following delivery of an Rh-positive baby to Rh-negative mothers
- After miscarriage, abortion, ectopic pregnancy, amniocentesis, chorionic villus sampling, or abdominal trauma in Rh-negative women
- Blood transfusion incompatibility prevention
- Dosage & Administration: Given as a single intramuscular injection as per physician’s guidelines
- Features & Benefits:
- Effectively prevents Rh sensitization
- Reduces the risk of hemolytic disease of the fetus and newborn (HDFN)
- Well-tolerated with minimal adverse effects
- Essential prophylactic measure for Rh-negative women
- Storage:
- Store at 2°C to 8°C
- Do not freeze
- Protect from light
Reviews
There are no reviews yet.